Inhibition of metastases by anticoagulants

M Hejna, M Raderer, CC Zielinski - Journal of the national …, 1999 - academic.oup.com
Metastasis involves several distinct steps, including one in which the tumor cell, after entry
into the bloodstream, comes to rest in a capillary located at the distant site where a …

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

M Raderer, B Kiesewetter… - CA: a cancer journal for …, 2016 - Wiley Online Library
Answer questions and earn CME/CNE Extranodal marginal zone lymphoma of the mucosa‐
associated lymphoid tissue (MALT lymphoma) accounts for 7% to 8% of newly diagnosed …

Esophageal cancer: a critical evaluation of systemic second-line therapy

CMR Thallinger, M Raderer, M Hejna - Journal of Clinical Oncology, 2011 - ascopubs.org
The objective of this article was to review clinical trials that used antineoplastic second-line
chemotherapy and/or targeted therapies in patients with esophageal cancer after first-line …

[HTML][HTML] Lanreotide in metastatic enteropancreatic neuroendocrine tumors

ME Caplin, M Pavel, JB Ćwikła, AT Phan… - … England Journal of …, 2014 - Mass Medical Soc
Background Somatostatin analogues are commonly used to treat symptoms associated with
hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects …

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled …

JC Yao, N Fazio, S Singh, R Buzzoni, C Carnaghi… - The Lancet, 2016 - thelancet.com
Background Effective systemic therapies for patients with advanced, progressive
neuroendocrine tumours of the lung or gastrointestinal tract are scarce. We aimed to assess …

T(14;18)(q32;q21) involving IGH andMALT1 is a frequent chromosomal aberration in MALT lymphoma

B Streubel, A Lamprecht, J Dierlamm… - Blood, The Journal …, 2003 - ashpublications.org
T (11; 18)(q21; q21) is the most common structural abnormality in extranodal marginal zone
B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) leading to the …

[HTML][HTML] Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

V Petkov, W Mosgoeller, R Ziesche… - The Journal of …, 2003 - Am Soc Clin Investig
Primary pulmonary hypertension is a fatal disease causing progressive right heart failure
within 3 years after diagnosis. We describe a new concept for treatment of the disease using …

[PDF][PDF] Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases

AI Schmatz, B Streubel, E Kretschmer-Chott… - J Clin …, 2011 - researchgate.net
Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of
Follicular Lymphoma: A Retrospective Stu Page 1 Primary Follicular Lymphoma of the …

[HTML][HTML] Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

ME Caplin, M Pavel, JB Ćwikła, AT Phan… - Endocrine-related …, 2016 - erc.bioscientifica.com
In the CLARINET study, lanreotide Autogel (depot in USA) significantly prolonged
progression-free survival (PFS) in patients with metastatic pancreatic/intestinal …

[HTML][HTML] ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic …

M Ghielmini, U Vitolo, E Kimby, S Montoto, J Walewski… - Annals of oncology, 2013 - Elsevier
To complete the existing treatment guidelines for all tumor types, ESMO organizes
consensus conferences to better clarify open issues in each disease. In this setting, a …